F
François Goldwasser
Researcher at University of Paris
Publications - 388
Citations - 15891
François Goldwasser is an academic researcher from University of Paris. The author has contributed to research in topics: Cancer & Sorafenib. The author has an hindex of 53, co-authored 357 publications receiving 12805 citations. Previous affiliations of François Goldwasser include French Institute of Health and Medical Research & Curie Institute.
Papers
More filters
Journal ArticleDOI
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
Bertrand Routy,Bertrand Routy,Bertrand Routy,Lisa Derosa,Lisa Derosa,Lisa Derosa,Connie P.M. Duong,Connie P.M. Duong,Maryam Tidjani Alou,Maryam Tidjani Alou,Maryam Tidjani Alou,Romain Daillère,Romain Daillère,Romain Daillère,Aurélie Fluckiger,Aurélie Fluckiger,Meriem Messaoudene,Meriem Messaoudene,Conrad Rauber,Conrad Rauber,Conrad Rauber,Maria Paula Roberti,Maria Paula Roberti,Marine Fidelle,Marine Fidelle,Caroline Flament,Caroline Flament,Vichnou Poirier-Colame,Vichnou Poirier-Colame,Paule Opolon,Christophe Klein,Kristina Iribarren,Laura Mondragón,Nicolas Jacquelot,Nicolas Jacquelot,Nicolas Jacquelot,Bo Qu,Bo Qu,Bo Qu,Gladys Ferrere,Gladys Ferrere,Gladys Ferrere,Céline Clémenson,Céline Clémenson,Laura Mezquita,Jordi Remon Masip,C. Naltet,Solenn Brosseau,Coureche Kaderbhai,Corentin Richard,Hira Rizvi,Florence Levenez,Nathalie Galleron,Benoit Quinquis,Nicolas Pons,Bernhard Ryffel,Veronique Minard-Colin,Patrick Gonin,Jean-Charles Soria,Eric Deutsch,Eric Deutsch,Yohann Loriot,Yohann Loriot,François Ghiringhelli,Gérard Zalcman,François Goldwasser,B. Escudier,B. Escudier,Matthew D. Hellmann,Matthew D. Hellmann,Alexander M.M. Eggermont,Alexander M.M. Eggermont,Didier Raoult,Laurence Albiges,Laurence Albiges,Guido Kroemer,Laurence Zitvogel +76 more
TL;DR: It is found that primary resistance to ICIs can be attributed to abnormal gut microbiome composition, and Antibiotics inhibited the clinical benefit of ICIs in patients with advanced cancer.
Journal ArticleDOI
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
David H. Henry,Luis Costa,François Goldwasser,Vera Hirsh,Vania Hungria,Jana Prausova,Giorgio V. Scagliotti,Harm Sleeboom,Andrew Spencer,Saroj Vadhan-Raj,Roger von Moos,Wolfgang Willenbacher,Penella J. Woll,Jianming Wang,Qi Jiang,Susie Jun,Roger Dansey,Howard S. Yeh +17 more
TL;DR: Denosumab was noninferior (trending to superiority) to ZA in preventing or delaying first on-study SRE in patients with advanced cancer metastatic to bone or myeloma and represents a potential novel treatment option with the convenience of subcutaneous administration and no requirement for renal monitoring or dose adjustment.
Journal ArticleDOI
Prevalence of malnutrition and current use of nutrition support in patients with cancer.
Xavier Hébuterne,Etienne Lemarié,Mauricette Michallet,Claude Beauvillain de Montreuil,Stéphane M. Schneider,François Goldwasser +5 more
TL;DR: The prevalence of malnutrition is high in patients with cancer, and systematic screening for and treatment ofnutrition is necessary.
Journal Article
Controlling Tumor Growth by Modulating Endogenous Production of Reactive Oxygen Species
Alexis Laurent,Carole Nicco,Christiane Chéreau,Claire Goulvestre,Jérôme Alexandre,Arnaud Alves,Eva Lévy,François Goldwasser,Yves Panis,Olivier Soubrane,Bernard Weill,Frédéric Batteux +11 more
TL;DR: In conclusion, antioxidant molecules may have opposite effects on tumor growth as SOD mimics can act in synergy with cytotoxic drugs to treat colon and liver cancers and reactive oxygen species can promote normal cellular proliferation and carcinogenesis.
Journal ArticleDOI
Management of hypertension in angiogenesis inhibitor-treated patients
Hassane Izzedine,Stéphane Ederhy,François Goldwasser,J-C. Soria,Gérard Milano,A. Cohen,David Khayat,J-P. Spano +7 more
TL;DR: No clear recommendation for an antihypertensive agent can be made in this context because there is a lack of controlled studies addressing the subject.